Most Recent Discussions

Sep 25 2020

Re: Rocklatan FDA Approved

Curious, I just started a patient (my first with this therapy) on Rocklatan after getting ZERO IOP change on generic Xalatan. He has been using it correctly for no more than two weeks but is complaining of bloodshot eyes. Is
read more

Jul 10 2018

Re: Longitudinal Study of Corneal Hysteresis

Great article, Jim, thanks.

Nov 27 2017

Re:

Clinician Topics

Glaucoma Watch: Interesting Glaucoma Cases; From Ocular Hypertension to Glaucoma: How to Predict Conversion; Neckties and IOP: The Controversy Continues; Introduction to the National Glaucoma Society; Case Presentation: Optic Nerve Imaging; NGS Residency Award and Lecture; Optic Nerve Head Measurements with the HRT III; Case Presentation: Laser Imaging Detects Early ON Damage; Is the Optic Disc "Sinking" or "Cupping" in Glaucoma?; Interview with Dr. Barry Barresi; Glaucoma Continuum; Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study; The Prevalence of Open-angle Glaucoma Among Blacks and Whites 73 Years and Older; Altered Nitric Oxide System in Patients with Open-Angle Glaucoma; Oxidative Stress in Glaucoma: A Burden of Evidence; Gonioscopy Videos; Glaucoma Risk and the Consumption of Fruits and Vegetables in Older Women; Programs to Optimize Adherence in Glaucoma; Corneal Hysteresis; Visual Field Interpretation; Study Questions link between Glaucoma and Alzheimer's Disease; Checking Color Vision; IOP Asymmetry as Glaucoma Risk Factor; Glaucoma Risk Calculators; Dr. David Calkins Discusses Catalyst for A Cure; Smart Phone Biosensor; Handheld OCT; Sustained Release IOP Therapies; Introduction to Corneal Hysteresis; FDT Perimetry; Visual Fields Overview; National Glaucoma Symposium 2017; Gonioscopy Slides from 2017 National Glaucoma Symposium; Measuring Corneal Hysteresis; XEN Glaucoma Implant Video; Corneal Hysteresis; Glaucoma Quality of Life Measures; Corneal Hysteresis: The A1C of Glaucoma; Predicting Progression; New Developments in Glaucoma Management; SECO Session on Innovations in Glaucoma; Longitudinal Study of Corneal Hysteresis; National Glaucoma Symposium 2018; DREAM Study; OIS at SECO; National Glaucoma Symposium Cape Cod; Is Glaucoma a Two-Pressure Disease?; ICD Stage Definitions; Visual Fields and Progression; OCT: The Basics; Co-Managing Glaucoma Surgery; Normal Tension Glaucoma; The Importance of Visual Fields; Corneal Hysteresis; Using OCT in Glaucoma Management; The LiGHT Study; Durysta Overview; Options in Glaucoma Surgery; Telemedicine in Glaucoma; Glaucoma Medications; New Visual Field Primer; Glaucoma Risk Factors; Drug Therapy for the Ocular Surface in Glaucoma; OCT Overview and Applications; Yoga as Adjunct Glaucoma Therapy; Cataract Surgery May Lower Risk for Dementia

In Your Office: Glaucoma Flowsheet; Tonometer Calibration; Pachymetry Coding; BCBS Coverage of SCODI Services; Expanded Coverage of Glaucoma Screening Services; Coding Update: 92135 Deleted and Replaced; ABO Certification Review Materials; Small Fee Reduction in CMS Payments in 2015; Moist Heat Compresses; Information about Omega-3s; Glaucoma Website for Patients; Beware of Phone Scam Posing as DPH or DEA; Tonography; Patient Assistance Programs; Plaquenil Reporting Form; World Optometry Day

Pharmacology Update: Extravan: Alcon Pharmaceuticals; Mechanism of IOP Reduction with Travoprost; Hydroxychloroquine Toxicity; Timolol; Upneeq Drops for Ptosis; Tetracaine Study

Clinical Guidelines: CCT: Is is time to say YES?; The Role of CCT in Glaucoma Patients; More CCT; The Paradox of IOP; Should We Treat All Ocular Hypertensives?; Beta Blockers in Glaucoma Management; Re-Defining Ocular Hypertension; Implications of Macro-Disc Asymmetry in Glaucoma Suspects; Nine-Year Changes in Intraocular Pressure: The Barbadoes Eye Studies; CyPass Clinical Recommendations; Optic Disc Cupping and Neuroimaging

Industry News: New FDA Approval for Lumigan; Alcon's Travatan Z Solution Receives FDA Approval; Alcon's Travatan Z and Systane Use Different Preservatives; Pfizer Sponsors New "All Eyes on Glaucoma" Website; CLIA Waivers; Bausch + Lomb New Glaucoma Drug; Glaukos iStent inject FDA Approved; Alcon Withdraws CyPass Stents; Nuretin Omega-3 Supplements; Rocklatan FDA Approved; Vivid Vision Perimetry; Falck Multifunction Device; Zeiss Medical Device Recall; Sustained IOP Reduction with iDose TR

Upcoming Programs

February 9, 2022

Dr. Brad Sutton will present "Fundus Autofluorescence: Applications for Clinical Practice" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific) on Wednesday, February 9.

February 23, 2022

Dr. Blair Lonsberry will present "Clinical Ocular Grand Rounds" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific) on Wednesday, February 23.

March 9, 2022

Dr. Eric Schmidt will present "60 Minute Glaucoma Update" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific) on Wednesday, March 9.

March 23, 2022

Dr. Nate Lighthizer will present "The Role of Laser in the Treatment of Glaucoma" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific) on Wednesday, March 23.

April 6, 2022

Dr. Mitch Ibach will present "Thick, Thin and Thinner: An Update on Endothelial Disease" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific) on Wednesday, April 6.

April 20, 2022

Dr. Danica Marrelli will present "Angle Closure Glaucoma" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific) on Wednesday, April 20.

May 4, 2022

Dr. Elizabeth Muckley will present "Ocular Trauma - Triage and Treatment" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific) on Wednesday, May 4.

May 11, 2022

Dr. Justin Schweitzer will present "The Nuances of Normal Tension Glaucoma" as a live webinar from 8:00-9:00 P.M. Eastern Time (7-8 PM.Central / 5-6 PM Pacific) on Wednesday, May 11.

June 25-26, 2022

The National Glaucoma Symposium 2022 will be a virtual program on Saturday and Sunday, June 25-26.

Your Registrations

You have no registrations currently in your cart.

News

NEW HAMPSHIRE ALLOWS 100% VIRTUAL CE IN 2022

The New Hampshire Board of Optometry has issued has a new standing order dated January 11, 2022 that authorizes all credit hours of continuing education to be obtained through virtual or alternative means in 2022. A copy of this order can be found on the New Hampshire Board of Optometry website (oplc.nh.gov) under Laws and Rules.

CE BROKER FOR TEXAS OPTOMETRISTS

The NGS will submit attendance data to CE Broker for Texas optometrists who attend our webinars. We will continue to mail CE certificates so attendees have a copy for their records and also will send attendance data to ARBO's OE Tracker.

NEW COPE RULES FOR INTERACTIVE WEBINARS

COPE has announced a transition period from January through June, 2022, while they develop new guidelines for online CE. During this transition period, live, interactive webinars will go back to being considered Interactive Distance Learning, but post-course tests will NOT be required. Thus, the NGS live webinars will be COPE approved as Interactive Distance Learning CE starting in January 2022. A number of states consider live, interactive webinars to be live CE, without restrictions on the number of credits, including: California, New York, Minnesota, Texas, Virginia and Vermont. For optometrists in those states, the COPE changes will not have an impact. Other states may consider the live webinars to be live CE (e.g., Pennsylvania for this renewal cycle) or may treat the live webinars as online CE with restrictions on the number of hours. Check with your State Board to determine how these hours will be treated for 2022.

PENNSYLVANIA CONTINUES TO ALLOW ONLINE CE

The NGS has just been notified that the Board of Optometry will continue to allow all CE to be online for the renewal period that ends November 30. 2022. There was communication that the waiver in Pennsylvania that allowed all CE to be virtual will end on September 30, 2021. However, to avoid confusion in the middle of the renewal cycle, the Board has decided to continue to allow all CE to be online.

MASSACHUSETTS GLAUCOMA LEGISLATION

On January 1, 2021, a bill was signed into law in Massachusetts giving optometrists the ability to provide glaucoma treatment, the last state in the country to do so. This new certification requires the completion of 20 hours of clinical education and 40 hours of didactic education. The law stipulates that these courses must be offered by the Massachusetts Society of Optometrists in conjunction with the two Massachusetts optometry colleges, NECO and MCPHS. This course is the only one that will meet the requirements of the law and be approved by the Division of Professional Licensure. Thus, none of the NGS webinars can be used toward the new glaucoma certification in Massachusetts.

NEW CHANGE PASSWORD FUNCTION ON WEBSITE

There is a new feature on the NGS website if you need to change your password. Sign into your account and click "Profile" to the right of your name at the upper right of the home page. The Profile page lets you know if you are a Full member of the NGS and, if so, when your membership expires. Click on "Change Password" which is to the right of your name on the Profile page. This will bring you to a page where you can put in your old password and then create a new password.

CALIFORNIA ALLOWS LIVE WEBINARS AS LIVE CE

The California Board of Optometry now recognizes interactive courses offered live over internet platforms such as WebEx as Live CE toward the 30 hours of live continuing education required for license renewal. Courses can be live COPE courses offered by COPE's June 30, 2021 deadline or courses approved by the Board.

NGS 1-HOUR WEBINARS

The NGS offers one-hour webinars September-December and January - May. These webinars are included in Full NGS Membership.

NGS LIVE WEBINARS = CATEGORY 1 ABO

We have received confirmation that the NGS live webinars now count as Category 1 Education towards American Board of Optometry (ABO) certification.

Join Our Email List

National Glaucoma Society